Literature DB >> 10718658

Determination of erythromycin, clarithromycin, roxithromycin, and azithromycin in plasma by high-performance liquid chromatography with amperometric detection.

C Taninaka1, H Ohtani, E Hanada, H Kotaki, H Sato, T Iga.   

Abstract

In this study, a high-performance liquid chromatographic method was developed for the quantitative determination of erythromycin (EM), roxithromycin (RXM), and azithromycin (AZM) in rat plasma with amperometric detection under a standardized common condition using clarithromycin (CAM) as an internal standard. This method was also proved to be applicable for the determination of CAM by employing RXM as an internal standard. Each drug was extracted from 150 microl of plasma sample spiked with internal standard under an alkaline condition with tert.-butyl methyl ether. The detector cell potential for the oxidation of the drugs was set at +950 mV. The linearity of the calibration curves were preserved over the concentration ranges of 0.1-10 microg/ml for EM and RXM, and 0.03-3.0 microg/ml for CAM and AZM. Coefficients of variation and relative error were less than 9% and +/-7%, respectively. The analytical method presented here was proved to be useful for the investigation of the pharmacokinetic characteristics of EM, CAM, RXM, and AZM in rats.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10718658     DOI: 10.1016/s0378-4347(99)00512-5

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  7 in total

1.  Possible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycin.

Authors:  Masami Sugie; Emiko Asakura; Ying Lan Zhao; Shoko Torita; Masayuki Nadai; Kenji Baba; Kiyoyuki Kitaichi; Kenji Takagi; Kenzo Takagi; Takaaki Hasegawa
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

2.  Pharmacokinetics of single- and multiple-dose oral clarithromycin in soft tissues determined by microdialysis.

Authors:  Friederike Traunmüller; Markus Zeitlinger; Petra Zeleny; Markus Müller; Christian Joukhadar
Journal:  Antimicrob Agents Chemother       Date:  2007-07-02       Impact factor: 5.191

3.  Comparative pharmacodynamic analysis of Q-T interval prolongation induced by the macrolides clarithromycin, roxithromycin, and azithromycin in rats.

Authors:  H Ohtani; C Taninaka; E Hanada; H Kotaki; H Sato; Y Sawada; T Iga
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

4.  Clinical pharmacokinetics and gastrointestinal tolerability of a novel extended-release microsphere formulation of azithromycin.

Authors:  Richa Chandra; Ping Liu; Jeanne D Breen; Jeannine Fisher; Charles Xie; Robert LaBadie; Rebecca J Benner; Lisa J Benincosa; Amarnath Sharma
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

5.  Development of a Simple RP-HPLC-UV Method for Determination of Azithromycin in Bulk and Pharmaceutical Dosage forms as an Alternative to the USP Method.

Authors:  Tayebeh Ghari; Farzad Kobarfard; Seyed Alireza Mortazavi
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

6.  The HPLC assay of concentration of azithromycin from two different manufacturers in gingival crevicular fluid (GCF).

Authors:  Mahmoud Khosravi-Samani; Khashayar Dehshiri; Sohrab Kazemi; Mohamadreza Shiran; Ali-Akbar Mohgadamnia
Journal:  Caspian J Intern Med       Date:  2016

7.  Comparison of microbiological and high-performance liquid chromatographic methods for determination of clarithromycin levels in plasma.

Authors:  Farzaneh Lotfipour; Hadi Valizadeh; Somayeh Hallaj-Nezhadi; Morteza Milani; Parvin Zakeri-Milani
Journal:  Iran J Pharm Res       Date:  2010       Impact factor: 1.696

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.